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Project Abstract/Summary
The Kentucky River Area District Health Department proposes implementation of
CHARM-Kentucky, a treatment program for pregnant women with opioid use disorder (OUD),
in eastern Kentucky. Over 115 Americans die each day from an opioid overdose, resulting in
approximately 42,000 deaths in 2016. In addition to an overall increase in opioid use in recent
years, the use of opioids in pregnancy has also increased from 1.19 per 1,000 hospital births in
2000 to 5.63 in 2009. Opioid use during pregnancy results in poor neonatal outcomes including:
low birth weight, preterm delivery, small head circumference, increased child maltreatment, and
risk for long-term foster care. There are many different professionals, both medical and nonmedical, that may be involved in the treatment, care, and decision-making surrounding a woman
with OUD and her baby. The CHARM program combines medication-assisted therapy (MAT)
with early access to prenatal care, counseling, early child welfare involvement prior to birth,
parenting education, nutrition support, and social services support. Participants in the program
receive prenatal care, access to MAT, participate in mandatory substance abuse counseling,
submit mandatory urine drug testing, attend group educational sessions relating to addiction and
parenting, and have coordination of services by a case manager. The original CHARM program
in Vermont has been shown to increase the number of women receiving treatment, move women
into treatment earlier in their pregnancy, increase infant birth weights, and have more infants
remain in the care of their mothers. CHARM-Kentucky will operate from the Primary Care
Centers of Eastern Kentucky Clinic in Hazard, a clinic serving communities significantly
burdened by the opioid epidemic in Kentucky.

Rice 3
Target Population and Need
The Opioid Epidemic
The United States (U.S.) opioid epidemic is a serious public health problem and was
designated as a public health emergency in 2017. Over 115 Americans die each day from an
opioid overdose, resulting in over 42,000 deaths in 20161. The rate of opioid-related deaths has
dramatically increased, and is now more than three times the rate in 19991. The financial impact
of the epidemic is estimated at $78.5 billion annually in healthcare costs, lost productivity, and
justice system involvement2.
Opioids are class of substances that include both prescriptions drugs (e.g., morphine,
oxycodone, hydrocodone, methadone, fentanyl) and illicit drugs (e.g., heroin and other synthetic
drugs). Opioids are highly addictive because they create a sense of euphoria, but they also cause
sedation, respiratory depression, and decreased gastrointestinal motility3. Opioid use disorder
(OUD) is defined as “a pattern of opioid use characterized by tolerance, craving, inability to
control use, and continued use despite adverse consequences4.” Opioid use is often accompanied
by an unstable lifestyle, decreased social structure, and drug-seeking behaviors, which
collectively increase the risk of injury and death5. The increase in opioid use is associated with
increases in adverse physical and mental health outcomes, including overdose, contraction of
infectious diseases, risk of assault, and neonatal opioid withdrawal syndrome among infants born
to opioid-abusing mothers.
This growing public health concern has prompted numerous federal agencies to respond
to the crisis. The U.S. Department of Health and Human Services (DHHS) and its agencies have
focused on increasing access to treatment, increasing public health surveillance, and allotting
research dollars to address the issue. The Centers for Disease Control and Prevention released
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the Guideline for Prescribing Opioids for Chronic Pain in 20166. The Food and Drug
Administration (FDA) issued guidance for the pharmaceutical industry to develop generic
versions of abuse-deterrent formulation of opioid medications and updated warnings and safety
information on existing opioid medications7. The Drug Enforcement Agency (DEA) rescheduled
hydrocodone containing products to a more restrictive controlled substance category8. Many
states, including Kentucky, have enacted prescription drug monitoring programs to track
controlled substance prescriptions as well as improve prescribing and dispensing9. Despite these
efforts, the opioid crisis continues to ravage the country.

Opioid Use During Pregnancy
In addition to an overall increase in opioid use in recent years, the use of opioids in
pregnancy has also increased from 1.19 per 1,000 hospital births in 2000 to 5.63 in 200910.
Opioid drugs are small molecules that easily cross the placental barrier to the fetus3. Neonatal
abstinence syndrome (NAS) is a withdrawal syndrome experienced by infants at birth after
exposure to drugs, primarily opioids, in the womb. In 2012, a baby was born with NAS in the
U.S. every 25 minutes11.
Opioid use during pregnancy results in poor neonatal outcomes including: low birth
weight, preterm delivery, small head circumference, increased child maltreatment, and risk for
long-term foster care5,10,12. Because opioid receptors are most common in the central nervous
system and gastrointestinal tract, opioid-related NAS is characterized by a high-pitched cry,
tremors, irritability, fevers, weight loss, and seizures. Babies born with NAS require more
expensive hospital stays, and are more likely to be covered by Medicaid10,11. Overall, babies that
require treatment for NAS have an average stay of 17-23 days compared to an average of 24-48
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hours for normal, healthy infants5. Babies that do not respond to non-pharmacologic therapy,
such as skin-to-skin contact and low stimulus environments, are treated with medications, such
as morphine and methadone, that are tapered over time. Additionally, infants with NAS that are
exposed to more than one substance during development are even more difficult to treat.
Women with OUD face many barriers to treatment, but without treatment, they face
increased risk of pre-term delivery, delivering low birth weight infants, and transmitting
infectious diseases to their infant13. Laws that sanction pregnant women with OUD and the
shame associated with the condition drive women away from available care or from seeking care
in the first place13. Many women present for medical care very late in pregnancy or when they
are in labor.

Medication-assisted therapy
Medication-assisted therapy (MAT) is the use of a medication – combined with substance
abuse counseling – to treat OUD. MAT is recognized as the most effective treatment for OUD,
including in pregnant women. MAT is widely accepted as the recommended standard of care and
is recognized as best practice by the American College of Obstetricians and Gynecologists4,5.
MAT reduces cravings and withdrawal symptoms, aiming to decrease the rates of relapse to
illicit drug use. Illicit opioid use can subject the fetus to repeated withdrawal episodes between
uses. Withdrawal, whether supervised or unsupervised, is not recommended because it can cause
spontaneous miscarriage and is associated with higher rates of drug relapse4,14. The positive
benefits of MAT are not only apparent during pregnancy, but continue after the child is born.
Mothers who are stable on therapy are encouraged to breastfeed, further improving the health of
the child14.
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Two common medications used in MAT have opioid receptor activity and are considered
opioid replacement therapy. These are methadone, a long-acting opioid receptor agonist, and
buprenorphine, a partial opioid receptor agonist. Methadone and buprenorphine are both taken by
mouth daily. Methadone has long been the standard therapy for MAT, however, buprenorphine
has been increasingly prescribed due to emerging data supporting its use15,16. Methadone is
dispensed daily by certified opioid treatment programs. Buprenorphine can be obtained by
prescription at a pharmacy. Both methadone and buprenorphine are acceptable therapy options,
and the choice between agents is made by physicians based on the characteristics and needs of
the patient. Although babies born to mothers stabilized on MAT may still experience NAS, the
benefits of the therapy still outweigh the risks that face the fetus in unsupervised opioid use. The
risks and benefits of MAT should be discussed in-depth with each individual.

The Kentucky River District
The Appalachain region of
Kentucky has been at the
forefront of the opioid epidemic.
Per Kentucky Revised Statute
211.687, cases of NAS are
required be reported to the
Kentucky State Health

Figure 1. NAS Rate in Kentucky Area Development Districts.

17

Department . From 2009-2012, the highest incidence of NAS in the U.S. was in the East South
Central region, including Kentucky, Tennessee, Mississippi, and Alabama11. The number of
newborns with NAS in Kentucky has increased 23-fold since 2001, with about 80% of these

Rice 7
births covered by Medicaid18. In 2015, there were over 110 cases of NAS each month across the
state. As noted in Figure 1 the Kentucky River Area Development District (KRADD), an 8county region in southeastern Kentucky, had the highest rate of NAS among all Kentucky Area
Development Districts, with an estimated 43.1-63.9 cases per 1,000 births reported in 2015,
compared to 24.3 at the state and national level respectively18. This region includes Breathitt,
Knott, Lee, Leslie, Letcher, Owsley, Perry and Wolfe counties. The KRADD has been
significantly impacted by the opioid epidemic. These counties are socioeconomically
disadvantaged and have some of the poorest health outcomes in the nation. A comparison of
relevant indicators can be found in Table 1.

Table 1. Comparison of the Social and Health Indicators of the KRADD, Kentucky, and the U.S.

Social Indicators
Median household income19
Medicaid enrollment (% of population)19,20
High school graduation, 201619,21
Drug arrests (per 100,000)19
Health Indicators
Total mortality rate (per 100,000)22
Infant mortality rate (per 100,000 live births)23,24
Proportion receiving adequate prenatal care19
Low birth weight19,25 (% of live births)
Proportion of deliveries covered by Medicaid26

KRADD

Kentucky

U.S.

$28,416
42%
71%
1,549

$43,740
22%
88.6%
1,476

$53,046
25.4%
84.1%

1,231
700
64%
11%
--

909
670
67%
9%
46%

823.7
587
77.1%
8%
42.6%

Healthcare services in the district, including opioid treatment centers, are limited.
Respondents to the 2015 Hazard Appalachian Regional Health (ARH) Community Health Needs
Assessment identified that “mental health, addiction treatment, and a birthing center” were
among the services that should be provided in Perry County27. The Hazard ARH Regional
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Medical Center Psychiatric Center is the state designated acute mental health facility for 21
counties in eastern Kentucky27. In 2017, there were 214 physicians certified to prescribe
buprenorphine to treat up to 30 patients, and 49 physicians certified to treat up to 100 patients28.
The only outpatient opioid treatment program in the Kentucky River District is the Behavioral
Health Group Center in Hazard, KY29. There are only five OB/GYN providers in the entire
district19. Hospitals in the area include: Hazard ARH Regional Medical Center, Jenkins
Community Hospital, Kentucky River Medical Center (Jackson), Mary Breckenridge Hospital
(Hyden), and Whitesburg ARH Hospital.

Program Approach
The CHARM Collaborative
There are many different professionals, both medical and non-medical, that may be
involved in the treatment, care, and decision-making surrounding a woman with OUD and her
baby. Professionals or organizations that may influence a woman’s care include obstetricians,
addiction specialists, child welfare workers, judicial system representatives, local hospital
systems, or clinics. Each of these professionals and organizations have different priorities and
policies that often lead to a disjointed or conflicting approach to ensuring the best outcome for
mother and child.
The Children and Recovering Mothers (CHARM) Collaborative began in Vermont in
2002 as an effort to address medical disparities and improve maternal and child health outcomes
in rural areas. It began when an addiction specialist opened the first methadone clinic and
coordinated care with a local obstetrician. The program attempts to address the five-points of
intervention framework to help reduce the potential harm of prenatal substance exposure
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recommended by the National Center on Substance Abuse and Child Welfare30: pre-pregnancy,
prenatal, birth, neonatal, and adolescence. CHARM not only addresses substance use, but also
provides a coordinated, comprehensive approach to other medical and mental health conditions,
and socioeconomic barriers that may co-exist with substance use disorder. Women with OUD
often come from unstable backgrounds, with little social and financial support, and have a
history of sexual or physical abuse14. This program emphasizes prevention to promote a safe
pregnancy, birthing experience, and childhood. The program combines MAT with early access to
prenatal care, counseling, early child welfare involvement prior to birth, parenting education,
nutrition support, and social services support. Participants in the program receive prenatal care,
access to MAT, participate in mandatory substance abuse counseling, submit mandatory urine
drug testing, attend group educational sessions relating to addiction and parenting, and have
coordination of services by a case manager. The CHARM Needs Assessment team consisting of
members of key services in the program meets monthly to identify gaps in care and aid in the
transitions of care of the participants. Since 2002, the Vermont CHARM Collaborative has
grown to a multidisciplinary group of 11 agencies that work together across multiple clinics to
identify and provide coordinated care for pregnant women with OUD and their babies from
conception through the beginning of the child’s life14. Currently, the Vermont-based CHARM
Collaborative serves 200-250 women and their families annually.
This community approach to opioid addiction in pregnancy has been shown to increase
access to care and improve neonatal outcomes12,14. The original study by Meyer and colleagues
compared women at a single institution receiving medication assisted therapy (methadone
administration) to women that received medication assisted therapy with improved coordination
of ancillary services. This study was conducted via retrospective chart review of the patient’s
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medical records. Over a 6-year study period, the Vermont CHARM program increased the
number of women receiving treatment for OUD at the clinic from 15 in the first two years of
program implementation to 51 women in the sixth year of the program. Women also received
treatment earlier in their pregnancy, starting treatment at 21.9 weeks during the first two years
compared to at 4 weeks in the sixth year of the program. Infant birth weights were significantly
higher in women who participated in the CHARM program compared to women who only
received opioid substitution therapy; 3016 grams vs 2816 grams, respectively. More than 90% of
infants born to women in the CHARM were discharged from the hospital in the care of their
mother compared to 69% of infants born to mothers who were not in the program. Furthermore,
women in the CHARM program were significantly more likely to retain custody of the infant at
1 year of age: 84.8% versus 62.5%.12. It is important to be cognizant of the fact that confounding
variables may have impacted the outcomes of this study, including the increased availability and
convenience of buprenorphine compared to methadone over the study period. As the authors
recognize, the outcomes are likely due to the synergism of multiple factors. Based on the
outcomes of this study, the CHARM program was recommended in 2016 as a collaborative
strategy for treatment of pregnant women with OUD by the Substance Abuse and Mental Health
Services Administration (SAMHSA)14. There are other U.S. programs similar to the Vermont
program, including in Ohio, North Carolina, and in central Kentucky, however, there are no
studies or outcomes that have been published on these programs to date.
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CHARM-KY
The Kentucky River District Health
Department (KRDHD) will implement CHARM-KY
to meet the needs of opioid-dependent pregnant
women in the KRADD. CHARM-KY will be modeled
after the Vermont CHARM project with minor
adaptations. Some ideas for CHARM-KY have also
been adapted from PATHways/Beyond Birth, a similar
Figure 2. The Kentucky River Area Development District.

program for pregnant women with OUD operating in
Lexington, Kentucky through the University of Kentucky College of Nursing. The CHARM-KY
Collaboration will be comprised of agencies and resources in the Kentucky River District and the
state of Kentucky. These partnering agencies include: Primary Care Centers of Eastern
Kentucky, Mountain Comprehensive Care, UK North Fork Valley Community Health Center,
Department of Community Based Services, Perry County Drug Court, Kentucky Health Access
Nurturing Development Services (HANDS), and Hazard Appalachian Regional Health (ARH)
Regional Medical Center. This collaboration will provide a means to efficiently share clientspecific information and coordinate care in the KRADD. A community advisory group (CAG)
will be established to guide implementation of CHARM-KY. Members of the CAG will include
representatives from the health departments in each county, Hazard ARH, the Center for
Excellence in Rural Health, local elected officials, the justice system, the police force, a domestic
violence program, and the Perry County Unlawful Narcotics Investigators, Treatment and
Education program. A further description of these partnering agencies and their role in the
program is discussed in Partnerships and Collaboration.
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Figure 3. Primary Care Centers of Easter Kentucky Clinic in Hazard, KY.

The CHARM-KY program will operate from an established clinic, Primacy Care Centers
of Eastern Kentucky (PCCEK), in Hazard, KY (Figure 2). The PCCEK clinic currently offers
on-site services including prenatal care, women’s health, pediatrics, and behavioral health31. The
PCCEK clinic has already been providing prenatal care to our target population and will be well
equipped to adopt the CHARM-KY program model. Using the clinic as a hub for CHARM-KY
services will allow women to receive almost all aspects of care at one site. At this clinic, women
will attend prenatal appointments, substance abuse counseling appointments, and group
education sessions. Additionally, the staff at PCCEK will be trained to connect CHARM-KY
participants to social services.

CHARM-KY: Enrollment and orientation
Women can be referred to the CHARM-KY program by any source: their local health
department, a substance abuse counselor, a hospital emergency department, their primary care
provider, a woman who is a current or former participant in the program, and/or by self-referral.
It is anticipated that the majority of participant enrollment will come from word of mouth and
social networks, similar to enrollment methods seen in the PATHways/Beyond Birth program32.
Women will be incentivized to refer other women needing CHARM services with a $20 gift card
for groceries.
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Each health department coordinator in the KRADD and community partner organization
will be given information on how to screen and refer women to CHARM-KY. All pregnant
women should be screened for OUD at the initial prenatal encounter, as recommended by
ACOG4. Health departments, primary care clinics, and other points of contact for our target
population will be informed of CHARM-KY and encouraged to use a screening tool, such as the
4Ps Plus, to identify and refer women who may benefit from the program. The “4P’s Plus”
screening tool has been well validated for use in pregnant women to identify alcohol use and
drug use, with a sensitivity of 87% and specificity of 76%4,33. If screening is positive, the
woman’s contact information will be communicated to the PCCEK clinic with her consent. The
CHARM-KY program coordinator will contact the woman within three days of receiving
notification from the woman or outside referral sources to establish care. During this call, the
program coordinator will screen the woman for appropriateness in the program. Three attempts
will be made by the PCCEK office to reach the woman to establish care.
During a woman’s first clinic visit, a detailed medical and social history will be taken by
the program coordinator. She will be assessed for OUD by the physician, her pregnancy will be
confirmed, and she will be tested for infectious diseases, such as viral hepatitis and HIV. If
pregnancy and OUD are both confirmed, the woman will be provided education on the CHARMKY program and given the opportunity to enroll. The woman must sign the Release-ofInformation Form, which states that she agrees that her personal information may be shared
between all CHARM-KY agencies for coordination of care. The woman must also sign a Care
Contract, which outlines the policies and expectations of both the providers and participants in
the CHARM-KY program. If a woman declines to enroll in CHARM-KY, she may continue to
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receive standard medical care, but it will not be coordinated for her by the CHARM-KY
program.

CHARM-KY: Care during the prenatal phase
After a woman has been enrolled in the program, the woman will meet with the social
worker to identify any social barriers that could interfere with the woman’s recovery. The social
worker will determine the woman’s insurance coverage status, housing status, and history with
the justice and child welfare systems. This information will be used to connect the woman to
services to meet her basic needs. She will attend scheduled prenatal appointments, counseling
appointments, and group education classes. It is the goal that the woman visits the PCCEK clinic
a minimum of once per week until she is considered stable. The schedule for prenatal
appointments will be made by the Leadership Team (see Project Management) in accordance
with national prenatal care guidelines. In an uncomplicated pregnancy, this is typically 10
prenatal visits34. During weeks when a woman does not have a prenatal appointment, she will be
scheduled to attend counseling or group education sessions. Group education sessions will cover
parenting education topics such as care of a newborn, breastfeeding, and caring for a baby with
NAS. Each session will be led by a PCCEK staff member or another professional well versed on
the topic (i.e., a session on domestic violence may be led by a representative from the Kentucky
Coalition Against Domestic Violence). A list of topics to be covered during education sessions
can be found in Appendix C. Each woman will be given a “Care Notebook” that includes a
summary of the CHARM-KY program, a list of local resources for services (i.e., medical,
transportation, housing, financial), forms to record medical information and child development
milestones, and frequently asked questions about pregnancy and child care. It will also include
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stories and encouragement from women who have participated in the program. Prior to delivery,
the woman will be educated by a nurse certified in obstetrics about what she should expect
during the hospital stay (e.g., possibility of neonate admission to NICU) and what she might
need to ask for (e.g., nicotine patches if she is a smoker).
In addition to prenatal care, the woman will receive services focused on mental health
and OUD. The woman will be assessed and initiated on opioid replacement therapy with
buprenorphine after enrollment. If she was on opioid replacement therapy outside the clinic, she
will be maintained on that therapy. In addition to medication, she will be required to participate
in substance abuse counseling with a certified drug and alcohol abuse counselor (CDAC). The
CDAC will be staff from Mountain Comprehensive Care who will come to the PCCEK clinic to
provide counseling services. Women will provide an observed urine drug screen at each
appointment at the clinic in order to receive a prescription for buprenorphine. The CHARM-KY
team will assess the woman for signs of relapse and the need for MAT dose adjustments during
each interaction at the clinic. Women deemed to be at-risk for relapse or that have recently
relapsed will be discussed at the monthly CHARM-KY meetings. The program will utilize a
system of Levels to describe the level of accountability she requires. This system will allow
CHARM-KY agencies to clearly identify what is required of each participant, and to identify
those that require more attention. For example, if a woman has had a recent relapse or disruption
to her home life, she may require a higher level of accountability from the CHARM-KY team.
The Levels systems is described in Appendix A. A woman must be actively engaged in treatment
and attending scheduled appointments to receive her prescription. Higher rates of program
retention are anticipated due to the opportunity to obtain MAT. Relapse is an expected part of the
recovery process. The program staff will work with the women in a supportive manner to work
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towards recovery during difficult times. However, if a woman enrolled in CHARM-KY
continuously uses illegal substances, misses pre-natal appointments repeatedly, or does not have
a safe living situation, the CHARM-KY members may notify child protective services. The
woman will be referred to an intensive outpatient or inpatient treatment center in the area.

CHARM-KY: Care during delivery
A goal for children born in the CHARM-KY program is to stay in the care of their
mother after birth. There will be a great deal of planning prior to the birth event to increase the
likelihood of that outcome. Women who have continued to use illegal substances during
pregnancy or are not stable on MAT will be discussed at the monthly CHARM-KY meetings
prior to delivery to make a plan for birth. This plan may include safety assessments conducted by
the Department for Community Based Services Protection and Permanency to identify additional
services needed or arrange alternative placement of the child after birth. This decreases the
likelihood of birth crises, such as emergency custody orders, during the delivery event. Women
who have attended at least 80% of their prenatal appointments and have been actively engaged in
recovery, will be given a car seat.
Women with uncomplicated pregnancies will be encouraged to give birth at Hazard ARH
Regional Medical Center, but they may give birth at any hospital. To standardize care for
CHARM-KY babies, a protocol will be developed by the CHARM-KY Leadership Team that
includes guidelines for the care coordination, the mother’s pain management, screening the
infant for NAS, and treatment for NAS symptoms. This protocol will be distributed to Hazard
ARH Regional Medical Center and other rural hospitals in the region. When a participant arrives
to Hazard ARH, the facility will contact the program coordinator within 24 hours to notify her of
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the delivery. After delivery, the neonate will be screened for NAS using the validated Finnegan
Neonatal Abstinence Scoring Tool5 and monitored for a minimum of five days. During the
hospital stay, a drug screen will be administered to both the mother and newborn. If the baby is
diagnosed with NAS, the facility is required to report the case to the Kentucky Department for
Public Health for surveillance purposes, in accordance with KRS 211.67617. Babies born to
participants will stay in their mother’s room after birth. The mother will be encouraged to take an
active role in the care of the newborn with skin-to-skin contact and breastfeeding. Babies
requiring treatment for NAS will be treated according to a protocol developed by CHARM-KY
providers.

CHARM-KY: Care post-partum
Babies born to CHARM-KY mothers will continue to receive care until 18 months, and
the mothers can continue to receive coordinated services for up to eight weeks after delivery.
Women in CHARM-KY will be scheduled for an appointment within 1 week of delivery. This
ensures that the mother is continuing the safe care plan following birth and that the infant is
receiving appropriate medical care. At this point, the PCCEK clinic pediatric staff will assume
care of the baby. The mother will remain on MAT, and continue to attend substance abuse
counseling and group education sessions. CHARM-KY will partner with the health departments’
Health Access Nurturing Development Services (HANDS) program to provide in-home nursing
visitations to aid in the transition of parenting at home.
After a woman’s participation in the CHARM-KY program ends, the case navigator
helps the patient establish care with a new MAT provider. This connection to care outside of the
program will prevent interruption of treatment. If a woman participated in HANDS, attended at
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least 80% of the recommended appointments and clinic visits, and actively engaged in recovery,
she will be given a gift certificate for 6-months worth of diapers. Additionally, she can elect to
complete training to become a peer support specialist. This will allow her to remain engaged in
the program, while providing valuable support to women still enrolled. In this role, she can earn
$25 gift cards for additional infant supplies.

Implementation
The first quarter of the first year will be used as a program planning phase. The program
planning phase will be utilized to recruit and hire staff, conduct a modified community health
needs assessment, and set goals. During this phase, program coordinators from the Vermont
CHARM program will be invited to Kentucky to train CHARM-KY leadership and staff. The
second quarter of year one will be used to train staff and meet with the CAG. Women can enroll
and participate in the program from quarter three of year one until quarter two of year three. This
allows time for the staff to be adequately trained before enrolling participants. Ending enrollment
with six months left in the grant allows time for staff to conduct data collection and outcome
evaluation analyses. A complete Gantt Chart can be found in Appendix E. An overview of the
inputs, activities, outputs, and outcomes can be found in the Logic Model in Appendix D.

CHARM-KY Adaptations
The Vermont CHARM program is over 12 years old and has had a significant amount of
time to implement all pieces of the program that make up the current iteration of CHARM.
CHARM-KY will be implemented as a pilot program operating from a single clinic to determine
the feasibility of the program in the Appalachian region with selected community partners.
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Additions to the CHARM-KY program, not present in the Vermont program, will be based on
the availability and usefulness of services in the area. For example, dental services were not
included in the CHARM collaboration in Vermont. Poor dental health is associated with poor
birth outcomes35. CHARM-KY will connect women to dental services provided by individuals
familiar with the program and its participants. Although the Vermont program did not utilize a
home visitation service for participants, the decision to partner with HANDS was made to
increase the supportive parenting services available to participants. The Vermont CHARM
program originally utilized both methadone and buprenorphine for MAT. However, since the
original publication, there have been many published studies supporting the use of
buprenorphine over methadone16. Due to the barriers to administering methadone, the CHARMKY providers will only utilize buprenorphine therapy for MAT.

Potential Barriers to Implementation
Barriers to program implementation were identified from those experienced in Vermont
and at the PATHways/Beyond Birth program. An anticipated barrier to the success of CHARMKY is the potential disagreement regarding treatment practices and legal implications between
agencies involved in the program. Reconciling differing views on legal, medical, and social
concerns will be important to maintain a standardized program approach. A solution to address
this barrier will be to include all partnering agencies in the initial planning discussions, and going
forward spend 10-15 minutes during each meeting for continuing education and cross-training
among members. These mini-educational sessions will be focused on educating members of the
CHARM-KY on issues important to the group. These may include: what constitutes an
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intervention from child protective services, what laws prevent and allow treatment with MAT,
and what services can be provided by social workers.
Another barrier anticipated in this program is the transient nature of our target population.
Clinic staff will maintain multiple contact phone numbers, email addresses, and mailing
addresses for women participating in the program, including asking the women permission to
contact family members as needed. Many women eligible for CHARM-KY may also have been
“fired” or discharged from the care of their community providers, including their OB/GYN
provider, due to their substance use. This can generate a distrust of the medical system and
potentially make it more difficult to engage women in care. Because few treatment facilities
accept pregnant women, the CHARM-KY program will eliminate that barrier to accessing care
for our target population. Our social worker will coordinate transportation and insurance
coverage for women to increase the likelihood of participation. Women will be encouraged to
bring other children they may have in their care to the clinic so that childcare is not a barrier. A
significant barrier many women face is that they may have partners or family members who are
also substance abusers. A full effort from the CHARM-KY collaboration members will be
necessary to connect the woman’s partner or family member with care outside the PCCEK clinic,
or at minimum decrease the interference on the woman’s recovery. Internal barriers faced by this
population include co-existing depression, anxiety, and guilt regarding their substance use.
Women will be required to see a counselor regularly, and this counselor will be utilized to build
a supportive community with other women in the program. Ultimately, the clinic staff will be
trained in-depth on the stressors faced by women in this population to decrease any
stigmatization they may feel. To address participant drop-out, an effort will be made to contact
women after they stop participation in the program to determine the reason(s). If the reason is
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related to barriers to accessing care, the social worker will work with the women to resolve the
issue (i.e., transportation, housing instability) in an effort to reengage her in the program. If the
woman declines to become reengaged, the program coordinator will record the primary reason
and use this information to guide programmatic refinements. If women do not like the program’s
structure, they will be connected to the nearest care provider in the area for prenatal and
addiction medicine services.

Sustainability of CHARM-KY
CHARM-KY will be primarily implemented by personnel who are already providing care
or services in the area. Partnering with established agencies in the region that have a vested
interest in the program’s outcomes will provide a larger network of support that can sustain the
program in the long-term. Financially, most personnel will be reimbursed for their services by
Medicaid. The program also depends heavily on Medicaid prescription drug insurance plans to
pay for the participant’s medications. Because of this, it is crucial that CHARM-KY maintain an
active and productive relationship with the Department for Medicaid Services through the
Department of Community Based Services. A potential barrier to program implementation is the
capacity of professionals in the region to take on additional caseloads. This is a valid barrier that
could diminish the potential impact of the program, and program leadership will need to alter
program recruitment efforts based on staff capacity to handle additional participants. In the longterm, the program may need to redistribute funds in the budget to recruit more professionals to
the area, including social workers and medical professionals. A future solution to this issue may
be the use of telehealth to provide services from off-site providers at the University of Kentucky,
for example. In 2018, the Kentucky state legislature heard bills in both the House and the Senate
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regarding Telehealth Services. The use of telehealth services has been recommended to increase
access for pregnant women in rural areas36.

Partnerships & Collaboration
Community Advisory Group (CAG)
The success of CHARM-KY will be dependent on the collaboration of the multiple state
and local agencies. To form a CAG, we have identified key members of the community who are
familiar with the people, resources, and the way of life in the area. By including community
stakeholders in the development of the intervention, we anticipate the likelihood of success in
implementation. The mayor of Hazard, Jimmy Lyon, has voiced support in the past for
interventions addressing the region’s opioid problem and he can provide insight into the city’s
inner workings. Inviting the director of the Center for Excellence in Rural Health to serve on the
CAG is important to learn more about program implementation in the district and what programs
have been attempted in the past. Participation from the Hazard Chief of Police will garner
necessary support from the criminal justice system. The LKLP Safe House in Hazard provides
shelter and services to domestic violence victims and their children, a population that may be
served by our intervention. Finally, asking a coordinator from each county health department to
participate in the CAG is critical to making connections in all of the communities our program
will reach. A complete list of CAG members can be found in Table 2.
Table 2. Community Advisory Group (CAG) Members
Administrator, Eastern Mountain Protection & Permanency/DCBS Service Region
Chairman, Perry County Board of Education
Chief of Police, Hazard, KY
Coalition Coordinator, Perry County Unlawful Narcotics Investigations, Treatment, and
Education (UNITE)
Community CEO, Hazard Appalachian Regional Health Regional (ARH) Medical Center
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Coordinator, Breathitt County Health Department
Coordinator, Knott County Health Department
Coordinator, Lee and Owsley County Health Department
Coordinator, Leslie County Health Department
Coordinator, Letcher County Health Department
Coordinator, LKLP Safe House Domestic Violence Program
Coordinator, Perry County Health Department
Coordinator, Wolfe County Health Department
Director, Center for Excellence in Rural Health
Field Representative for Congressmen Hal Rodgers, Hazard District
Mayor, Hazard, KY
Program Supervisor, Perry County Adult Drug Court

CHARM-KY Collaboration Partners
Collaboration partners not only provide additional insight into the community our
program will serve, but they will play an active role in implementation of our intervention. All
members of the collaboration already work with members of the CHARM-KY target population
in some capacity. Dr. John McKinney of the PCCEK clinic has confirmed interest in the
CHARM-KY program and agreed to use his clinic as the hub for services. Because his clinic
already serves pregnant women with OUD, he has a vested interested in the outcomes of
CHARM-KY. Local social services, including the Department of Community Based Services,
are already working with our target population. Including the Perry County Protection and
Permanency Family Services Office and the Eastern Mountain Family Support Services Office
will facilitate the coordination of child welfare, violence prevention, nutrition support services,
and Medicaid/CHIP enrollment services for CHARM-KY participants. Prescription insurance
coverage for eligible women and children is vital to the success of the program. The completion
of prior authorization paperwork is required by most insurance plans to cover medications, such
as buprenorphine, used in MAT. Completing prior authorizations requires communication
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between the pharmacy, provider, and insurance company. It can take anywhere from days to
weeks, and is often a barrier to the patient accessing their prescribed medication. Uniting the
Pharmacy Care Center with the other partners in this collaboration will expedite this process.
Including Hazard ARH in the collaboration is important to increase communication between
hospital and community providers before and during births. The HANDS program is a wellestablished home visitation program for new or expectant parents to help build a healthy and safe
environment for the child’s development, and serves over 10,000 families across Kentucky each
year37. This existing program’s experience in facilitating home visitation, working with pregnant
women and new mothers, and providing connection to local services will be beneficial in
implementing these aspects of CHARM-KY. Table 3 describes the roles of CHARM-KY
collaboration members.
Representative
Jordan Price, MPH
Leslie Atkins, BSN,
RNC-OB
John McKinney, MD

CHARM-KY Collaborative
Members/Agencies
Program Coordinator;
CHARM-KY
Program Director; Pregnancy
and Beyond program,
PCCEK Clinic
Physician; PCCEK Clinic

Member/Agency Role
Director of CHARM-KY Collaboration
Coordinator of care services for participants
Provide nursing services and education to
participants
Provide prenatal and mental healthcare
Provide physician and nursing staff
Facilitate case management and connection
to social services

Representative, LCSW Case navigator; PCCEK
Clinic and Mountain
Comprehensive Care, Hazard
Jill Powell, CDAC
Clinic Coordinator;
Provide MAT after graduation from program
Mountain Comprehensive
Care, Hazard
Sharon Barker, DMD
Dentist; UK North Fork
Provide dental services for participants
Valley Community Health
Center
Valerie Smith
Supervisor; Perry County
Coordinate child welfare and violence
DCBS Protection and
prevention
Coordinate Medicaid & KCHIP enrollment
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Francis Walters

Elizabeth Wells
Jacquelyn Williams

Margret Timothy

Karen Burt, PharmD

Permanency Family Services
Office
Supervisor; Eastern
Mountain DCBS Family
Support Services Office
Circuit Court Judge; Perry
County Adult Drug Court
KRAD Coordinator;
Kentucky Health Access
Nurturing Development
Services (HANDS) Program
Director of Community
Engagement; Hazard ARH
Regional Medical Center
Pharmacist; Pharmacy Care
Center and PCCEK

Coordinate assistance for domestic violence
victims
Coordinate Supplemental Nutrition
Assistance and WIC Program benefits
Facilitate Medicaid enrollment
Aid in navigation for women in justice
system
Provide education on parenting skills and
child health
Conduct home health nurse visits after birth
Connection to local acute care services

Provide pharmacy services and coordination
of medication access

All member organizations participating in CHARM-KY must sign a memorandum of
understanding to share information regarding each of the individuals enrolled. Shared
information may include name, living situation, health history, psychiatric history, substance use
history, criminal history, and previous encounters with child protective services. The CHARMKY providers will meet once monthly for 2 hours to discuss patient cases and program
implementation. This will increase communication between providers and enhance the
coordination of care. This allows for time for team members to disclose pertinent information
that they have learned regarding a participant or their situation with the larger group. During
these meetings, each person involved in the project will provide status updates to identify where
problems or delays in program implementation.
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Performance Measures & Evaluation
Overview
The purpose of the evaluation will be to assess the program’s feasibility and provide that
information to CHARM-KY stakeholders. The primary goal of CHARM-KY is to improve
maternal-child health outcomes in eastern Kentucky, and evaluation of our program will be
guided with this outcome in mind. Conducting both process and outcome evaluation of
CHARM-KY will enable program leadership to monitor the program’s progress towards its goals
and use that data to improve the program. Our Evaluation Team will be by comprised of our
Program Director, Dr. Scott Lockard; our Program Coordinator, Jordan Rice; a current or former
participant of the PATHways program in Lexington; an evaluation consultant from the Kentucky
Department of Public Health; and a biostatistician from the University of Kentucky College of
Public Health. Evaluation activities for CHARM-KY will be guided by input from stakeholders
in our program:
•
•
•
•
•

CAG members
CHARM-KY collaboration partners
Staff of the PCCEK clinic
Members of our target population
Funding agency

Formative Evaluation
Before enrolling the first participant, we will conduct a focus group with each of our
stakeholder groups including (1) women from our target population, (2) proposed staff, (3)
members of the CHARM-KY collaboration agencies, and (4) members of the CAG to assess the
feasibility and appropriateness of CHARM-KY and its components. Potential topics of
evaluation may include: What would you like this program to accomplish? How could we get
you to enroll in the program? What is important to you about this program? What are your
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concerns about this program? How will you use the results of the program evaluation? Program
materials, such as the Care Notebook, will be evaluated in these sessions as well. Conversations
will be recorded, professionally transcribed, and coded for themes by the program coordinator.
Results of the focus groups will be used to inform the development of implementation and
outcome measures.

Process Evaluation
The program will utilize process evaluation as recommended by the CDC38 to determine
if the program is implemented as planned, what resources are being utilized, and who is reached
as a result. To evaluate implementation of our program, the Evaluation Team will monitor and
analyze a variety of components, including measures related to operations, staff engagement, and
participant engagement. Results from process evaluation measures will be compiled and
presented to stakeholders at the collaboration meetings each quarter, and to the funding agency
on an annual basis. A complete description of these components can be found in Table 4.
Process Measure
Program operations
CAG perception of CHARM-KY
program prior to program initiation
Number of staff trained on CHARM-KY
Proportion of women who screen
positive for OUD in the community and
enroll in CHARM-KY
Content of group education sessions
Participant referral source
Participants seen within 1 week of
referral
Staff satisfaction and engagement
Collaboration members’ perception of
appropriateness & effectiveness of
CHARM-KY collaboration

Data Source(s)

Responsible Person(s)

Time Frame

Focus group;
Key informant
interviews
Training log

Program coordinator

Quarter 1,
Year 1

Program coordinator

Referral form

Program coordinator

Quarter 2,
Year 1
Quarterly

Observation
Referral form
Intake form

Program coordinator
PCCEK manager
PCCEK manager

Quarterly
Quarterly
Ongoing

Partnership
survey

Program coordinator

Quarterly
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Teamwork of CHARM-KY collaboration Partnership
members
survey;
Meeting minutes
Engagement of staff at PCCEK
Staff survey
Number of partners present at CHARM- Meeting
KY meeting
attendance log
Participant satisfaction and engagement
Proportion of women completing
Participant
CHARM-KY program
record
Reason why participants left program
Participant
record
Participants’ perception of group
Participant
educational sessions
survey
Number of women enrolled in CHARM- Participant
KY
record(s)
Number of participants at group sessions Group session
attendance log
Number of scheduled appointments
Participant
attended
record
Number of recommended group sessions Group session
attended
attendance log
Participant’s perception of CHARM-KY Participant
survey
Length of enrollment in CHARM-KY
Participant
record

Program coordinator

Quarterly

Program coordinator
Program coordinator

Quarterly
Monthly

Program coordinator

Quarterly

PCCEK manager

Ongoing

Program coordinator

Quarterly

Program coordinator

Monthly

Group session leader

Ongoing

PCCEK manager

Quarterly

PCCEK manager

Quarterly

PCCEK manager

Quarterly

Program coordinator

Quarterly

Data collected for the process evaluation will be obtained via the participants’ medical
records, referral forms, and the partnership/staff/participant surveys. During the planning phase,
the program coordinator will be responsible for collecting and compiling results from the focus
groups and key informant interviews. Providers in the community will complete a referral form
for woman they refer to CHARM-KY, regardless if the woman chooses to enroll. The PCCEK
Clinic Manager will compile referral forms on a quarterly basis. The sources will be evaluated to
determine if recruitment methods should be adapted. When a woman is enrolled in the CHARMKY program, the PCCEK manager will complete an intake form.
To monitor the engagement of key stakeholders in the program, surveys will be
distributed quarterly to staff and collaboration members, and on a rolling basis to participants.
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Findings from these surveys will be discussed by the Leadership Team on a quarterly basis and
presented to the collaboration members. Participating women will be surveyed at their first and
fifth CHARM-KY encounter, at the first visit following birth, and at the conclusion of their
enrollment. This survey will evaluate the mother’s perception of the program, its application and
impact on her and her family, strengths of the program, and areas in need of improvement.
The monthly meeting minutes will be analyzed to determine how much time is spent
discussing patient cases versus program implementation issues. Monitoring the number of
participants in the group sessions will help program staff identify the need to adjust clinic
days/times, topics for group discussion, and outside forces that are interfering with participation.
The CARE Notebook will be evaluated by the first five participants in the program to
ensure that the resources are relevant, written at the appropriate literacy level, and that it is well
received before continued use. To ensure that mothers are being adequately educated, each group
educator (i.e., nurse educator, drug and alcohol counselor) should utilize the teach-back method
with the program director annually. Many different professionals will be leading the group
education sessions, and the program director should use a checklist to evaluate each educator’s
delivery and ensure fidelity across sessions. Process evaluation results will be presented at the
annual CAG meetings and each quarter at the CHARM-KY member meetings.

Outcome Evaluation
The target population of this intervention is a sensitive and transient one, making
outcomes comparison challenging. The outcomes measured will be similar to those evaluated in
the Vermont CHARM program. The primary outcomes used to evaluate the Vermont CHARM
program included: gestational age when the woman entered treatment, birth weight, infant
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discharge in maternal care, and infant in maternal care at one year12. Baseline demographic data
from women and neonates in the CHARM-KY program will be compared against data for
women and their neonates who were referred to CHARM-KY, but chose not to enroll. This data
will come from referral forms completed by community referral sites. The outcome evaluation of
CHARM-KY will be conducted by comparing outcomes of participants to regional and state
level data. The program will partner with the Kentucky Department of Public Health to obtain
maternal-child health data. Data will be collected and recorded securely in REDCap. A Data
Analyst from the Center for Excellence in Rural Health will extract pertinent data via chart
review. Each woman will be given a unique identifier to be used in analysis. A dose effect
analysis will be conducted to determine if the number of prenatal appointments, counseling
sessions, use of the Care Notebook, attended has any impact on illicit drug use and birth outcome
measures. A survey administered to participants will include questions from the Interpersonal
Support Evaluation List to measure social support39. Results will be discussed with the CAG
meetings annually.
Table 5. Outcome Measures.
Outcome Measure
Number of NICU admissions
Birth weight < 2500 grams
Proportion of infants delivered at < 37
weeks
Length of hospital stay
Adequate prenatal care (80% of
recommended visits received)
Number of Prenatal visits attended
Self-efficacy in parenting
Perception of positive social support
Intent to remain sober
Infant in maternal care at delivery
discharge

Data Source(s)
Medical record
Medical record
Medical record

Responsible
Person(s)
CEHR Data Analyst
CEHR Data Analyst
CEHR Data Analyst

Time Frame
Annually
Annually
Annually

Medical record
Medical record

CEHR Data Analyst
CEHR Data Analyst

Annually
Annually

Medical record
Participant survey
Participant survey
Participant survey
Medical record

CEHR Data Analyst
CEHR Data Analyst
CEHR Data Analyst
CEHR Data Analyst
CEHR Data Analyst

Annually
Annually
Annually
Annually
Annually
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Number of drug screens negative for
illicit substances at delivery
Gestational age at start of CHARMKY
Number of women sober at discharge
from program
Participation rate in HANDS
Infant in maternal care at 1 year
Uptake of social services

Medical record

CEHR Data Analyst

Annually

Medical record

CEHR Data Analyst

Annually

Medical record

CEHR Data Analyst

Annually

CHARM record
CHARM record
CHARM record

CEHR Data Analyst
CEHR Data Analyst
CEHR Data Analyst

Annually
Annually
Annually

Capacity and Experience of the Applicant Organization
The mission of the Kentucky River District Health Department (KRDHD) is to “protect,
maintain, and promote the health of the people of the community”40. This department is a
regional health department that serves seven of the eight counties in the KRADD: Knott, Lee,
Leslie, Letcher, Owsley, Perry and Wolfe. The application for funding aligns with the goals of
the organization’s mission statement to connect groups and agencies to improve the access and
provision of healthcare and social services, including to pregnant women with OUD in the
district.
The department has experience in implementing multiple programs in the community,
including: Breastfeeding classes, Breastfeeding support groups, Ladies’ Health Days, Freedom
from Smoking classes, Diabetes Self-Management Education classes, Eating Health in Kentucky
Cooking School, and a partnership with HANDS program. Participants in the District’s Freedom
from Smoking Classes are 85% more likely to quit40. In 2016, over 150 individuals participated
in the smoking cessation classes. During Ladies’ Health Days, the District coordinates physical
exams, pap smears, breast exams, and appropriate lab work for participants41. They frequently
partner with local schools to host educational programs to the public on topics such as driving

Rice 32
under the influence, teen pregnancy, hand hygiene, and physical activity. Most closely related to
CHARM-KY is the department’s experience in providing prenatal services.
The KRDHD is led by Public Health Director Dr. Scott Lockard. Dr. Lockard has over 20
years’ experience in public health leadership and programming. He has served as the primary
investigator on the HANDS project and was instrumental in starting needle exchange programs
in the district. His experience in the field of early childhood programming will be advantageous
to CHARM-KY. He has been awarded over $4 million in grant awards for community programs
and public health research in the topics of women’s health, published in the American Journal of
Public Health and the Journal of Obstetric, Gynecologic, & Neonatal Nursing. He has led
numerous community health needs assessments and shared findings with community action
councils. Annually, he manages a budget of over $1,250,000 and serves as the direct supervisor
of over 40 employees.

Project Management
Leadership
To meet the above goals, the CHARM-KY Collaborative will be guided by the
Leadership Team. The Leadership Team will be responsible for overseeing all aspects of
program implementation and evaluation. They will serve as the ultimate decision making body
and represent the interests of the partners and participants. The Leadership Team will consist of:
•
•
•

Tim Stockton, DrPH, MSW, CSW (CHARM-KY Program Director)
Jordan Rice, MPH (CHARM-KY Program Coordinator)
Leslie Atkins, RN (CHARM-KY Assistant Coordinator, PCCEK Coordinator)
Tim Stockton, DrPH, MSW, CSW, will serve as the program director (PD). Dr. Lockard

earned his Master of Social Work and Doctor of Public Health from the University of Kentucky,
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and is a 2011 graduate of the National Public Health Leadership Institute. Dr. Lockard currently
serves as the Public Health Director for the Kentucky River District Health Department
(KRDHD), and is past president of the Kentucky Health Departments Association. He will be
responsible for the program design, implementation, process and outcome evaluation, and
dissemination of final program results.
Jordan Rice, MPH, will serve as the project coordinator. Jordan earned her Master of
Public Health from the University of Kentucky and currently serves as Public Health Program
Specialist for the KRDHD. Ms. Rice has led the implementation of programs in the region
including Ladies Health Days, Breastfeeding classes, and Freedom from Smoking classes. As the
project director, she will be responsible for (1) management and engagement of key
stakeholders, including oversight of and communication with CHARM-KY partners and the
CAG, (2) staff training, (3) data collection, and (4) monitoring program implementation. Ms.
Rice will organize and lead monthly meetings with the entire CHARM-KY Collaborative team
to provide updates on the program and discuss care for current participants.
Leslie Atkins, BSN, RNC-OB, will serve as the Assistant Coordinator and PCCEK
Coordinator. She has served as Program Director for the Pregnancy and Beyond program at the
PCCEK clinic for five years. She worked for 10 years as a labor and delivery nurse before
transitioning to her role at PCCEK. Ms. Adams earned her Bachelor of Science in Nursing at
Morehead State University and is certified in Obstetrics. Her role in CHARM-KY will be
primarily administrative; she will (1) manage the recruitment, enrollment, and management of
program participants, (2) act as liaison for the PCCEK clinic to the CHARM-KY Leadership
Team, and (3) oversee daily clinic operations. She will focus on participant satisfaction and care
coordination.
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Staff
Medical professionals, as well as mental health support staff, are key to the
implementation of CHARM-KY. Dr. John McKinney, MD, is a dual board certified MaternalFetal Medicine and Addiction Medicine physician. He is a certified Buprenorphine provider in
accordance with the Drug Addiction Treatment Act of 2000 and is currently a practicing partner
of PCCEK. He will provide both obstetric and mental health care to program participants,
including examinations, prenatal management, and providing prescriptions for MAT. Michelle
Hatton, RNC-OB, is currently on staff at PCCEK and provides prenatal nursing care. The nurse
will be responsible for conducting group classes on prenatal care, fetal development,
breastfeeding, and parenting, for example. The nurse will also work closely with HANDS to
coordinate post-partum in-home visitation for participants. Jill Powell, CADC, is a certified
alcohol and drug counselor at Mountain Comprehensive Care Center in Hazard. Other staff that
we will recruit for include a social worker and a data analyst. The data analyst will be
contracted from the Center for Excellence in Rural Health to extract pertinent data from medical
records and compile information for evaluation. Each month, all representatives from the
collaborative agencies will meet for 2 hours to discuss participants new to the program,
participants expected to give birth in the next 30 days, participants who have recently given
birth, and participants that any agency has concerns about.
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Budget Narrative
Grant budget period: July 1, 2018 – June 31, 2021
A. Anticipated Enrollment.
Year 1

Year 2
15

Year 3
30

TOTAL
40

85

The number of women who will participate in CHARM-KY is estimated from the number of live
births in the KRADD annually, the rate of NAS in the region, and participation in the Vermont
CHARM program. In the Vermont CHARM program, 15 women were treated during the first
year, 24 during the third year, and 51 during the fifth year12. The average number of births in the
KRADD annually from 2014-2016 was 1,36742, and the rate of NAS in KRADD is estimated at
63.9 per 1,000 births18. With this data, we estimate that at least 85 women would be eligible for
enrollment in CHARM-KY annually. This information has been used to estimate a total grant
period enrollment goal of 85; with 15, 30, and 40 in the first, second, and third years of the grant
respectively.

B. Personnel Salaries and Wages.
Position Title
Principal Investigator

Annual
Salary
$130,000

Program Coordinator
Assistant
Coordinator/PCCEK
Manager
Registered Nurse

% FTE

Salary

Fringe

Total

20%

$26,000

$7,611

$33,611

$80,000

70%

$56,000

$19,202

$75,202

$52,000

30%

$15,600

$6,445

$22,045

$50,000

20%

$10,000

$4,211

$14,211
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MaternalFetal/Addiction
Medicine Physician
Certified Alcohol and
Drug Counselor
Social Worker

$225,000

20%

$45,000

$11,649

$56,649

$35,000

10%

$3,500

$1,787

$5,287

$45,000

20%

$9,000

$3,999

$12,999

$168,100

$56,585

$224,685

TOTAL PERSONNEL
Table above reflects budget for Year 1.

Most the CHARM Collaborative budget will be dedicated to supporting personnel and licensed
healthcare providers. The CHARM-KY principal investigator will oversee the implementation of
the program, but the Program Coordinator will manage the program on a daily basis. The
Program Coordinator will spend the majority of her efforts on program implementation and
management of all collaboration agencies. The PCCEK Manager will coordinate the program’s
implementation at the PCCEK Clinic specifically, and should 1.5 to 2 days/week to work on
program activities. Medical professionals are necessary for this project as they possess the
training and licensure required for the diagnosis, management, and authority to write
prescriptions of OUD treatment and care. A specialized license is required by Federal and
Kentucky State law for medical doctors to write prescriptions for MAT, and the specialization of
the dual board certified physician is ideal for the CHARM-KY program. Registered nurses are
necessary to appropriately meet the specialized medical, prenatal, and behavioral health needs of
individuals in this program. The medical providers will receive reimbursement equal to what
they would make in their full-time position. During the first year, staff will need to be trained in
program implementation. During this time, experts from the CHARM Collaborative in Vermont
will be invited to speak to and train our team. Their insight into the development and
implementation of this project is imperative for a successful beginning. Our budget will allow for
compensation for this individual’s time, travel, and lodging in Kentucky.
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Contractual
CHARM-KY will contract professionals in data analysis and management to aid in program
evaluation. A biostatistician from the University of Kentucky will be hired on a contractual basis
to perform analysis of program data during years 2 and 3 (salary $85,000). CHARM-KY will
hire a data analyst from the Center for Excellence in Rural Health to extract data from health
records and record that data in REDCap during years 2 and 3 (salary $45,000).

C. Supplies.
Item

Number
needed

Unit cost

Year 1

Year 2

Year 3

Monthly
meeting food
Care
notebook
Save-A-Lot
Gift Card
Car Seat

Variable

$145/meeting

$1750

$1750

$1750

90

$30

$900

$900

$750

70

$20

$600

$600

$200

90

$100

$3000

$3000

$2500

Gift card for
infant
supplies
Total
supplies

100

$25

$1000

$1125

$375

$7250

$7375

$6325

Supplies required for program implementation include materials to make the Care Notebooks,
participant incentives, and food for collaboration meetings. We will overestimate supplies
needed during the first year (n=30), in case there is a higher enrollment than anticipated. The
following will be required for notebooks: printer paper, 3-ring binders, printer ink, pens, and
notepads. During the first year, 20 notebooks will be made, with 30 and 50 made the following
years based on anticipated enrollment. We estimate each notebook will cost $30 to produce.
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Each participant will be given the opportunity to earn incentives. Participants will be given $20
gift cards to Save-A-Lot for each referral made. She will earn a car seat estimated at $100 prior
to birth if they attend 80% of recommended sessions. If the woman decides to become a peer
support specialist after graduation from the program, she can earn $25 gift cards for infant
supplies, such as diapers, for each group session she conducts. Participants will also earn $25 gift
cards for completing participant surveys. Food will be provided to at least 12 collaboration
members at each monthly meeting at an estimated cost of $125/meeting.

C. Travel.
Year 1
APHA Annual
Meeting Registration
Flight
Lodging
Local State Travel
TOTAL

Year 2

Year 3

$1,000

$1,000

$1,030

$1,000
$1,000
$2,000
$5,000

$1,000
$1,000
$1,000
$4,000

$1,000
$1,000
$1,000
$4,030

Our program leadership will travel locally in the district to train personnel, promote the program,
and oversee implementation. The furthest county seat from Hazard is Campton, KY in Wolfe
County at 49 miles. We estimate that the Leadership Team will travel throughout the district
more frequently during the first year than in subsequent years. At the standard reimbursement
rate of 53.5 cents/mile, we will estimate travel throughout the district at $2,000 in year one, and
$1,000 in years two and three.
Promotion and dissemination of the project and its results will be an important
contribution to the public health and substance abuse community. Our project background and
methods will be presented by two staff members at the American Public Health Association
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annual meeting at the end of year one, preliminary outcome results at the end of year two, and
final results at the end of year three. The budget will account for meeting registration, lodging,
and travel to present our project findings across all three years of the grant. The 2019 annual
meeting is in Philadelphia. Our grant will budget $1,000 for registration, $500/ticket for airfare,
and $250/night for lodging for two rooms for nights at an estimated total attendance cost of
$3,000.

D. Equipment.
CHARM-KY will require no additional equipment outside of the already established
clinic; services, exams, medications and lab tests will be paid for by insurance.
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Appendix A. Description of accountability level system32.

Level of Accountability in CHARM-KY
Level
Criteria
1
Negative drug screens for at least 1 month and
No reported relapse in the last month and
1 or less missed appointments
2
Positive drug screen for illicit drug use and/or
Reported relapse within the last two months and/or
2 missed appointments within the last month
3
History of habitual illicit drug use and/or
Reported relapse within the last month and/or
3 or more missed appointments within the last month
Adapted from PATHways Phase System Overview.

Prescription Policy
Prescriptions are written
for a maximum of 14
days
Prescriptions are written
for a maximum of 7 days
Prescriptions are written
for a maximum of 4 days
or until next appointment
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Appendix B. Patient information and data to be collected. This list serves as an example of data
to be collected and is not conclusive.
• Demographic
o Number of children
o Marital status
o County of residence
o Employment status
o Education completed
o Housing status
o Transportation status
o Insurance status
o Age
• Medical (behavioral health)
o Mental health conditions
o Drug use (substance, route of use)
o History of recovery attempts
• Medical (obstetrics)
• Medical (other)
o Other health conditions
o Tobacco use
• Neonatal
o Birth weight
o Gestational age at birth
o Drug screen of neonate at birth
o Treatment required for NAS
o NICU admission
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Appendix C. CHARM-KY Materials.
Examples of education topics:
•
Breastfeeding
•
Giving birth
•
Nutrition for newborn
•
Nutrition during pregnancy
•
Birth control and family planning
•
Domestic violence
•
Financial planning (balancing checkbook, etc)
•
Applying for jobs
•
Decision making
•
Smoking cessation

The Four P’s Plus screening tool33:

Logic Model
Inputs

Activities

Outputs

Funding
Agency

Provide
Prenatal Care

Medical
Personnel

Provide
Medication
Assisted
Treatment

Uptake in
prenatal care
services

Community
Partners
PCCEK Clinic

Connection to
services

CHARM
Vermont

Group
education
Post-natal
care

Women
engaged in
substance
treatment
Uptake of
social services

Early
Outcomes

Later
Outcomes

Adequate
prenatal care

Improved
neonatal
health
outcomes

Reduction in
illicit drug use
Increased
engagement in
treatment
Increased health
outcomes at
birth
Increased selfefficacy in
parenting

Improved
child safety
Maintenance
of recovery
Program is
broadly
adopted

July 1, 2018 - June 31, 2021
Year 1
Effort
Personnel
Principal Investigator
Program Coordinator
Assistant Coordinator/PCCEK Manager
Registered nurse, Obstetrics
Maternal/Fetal/Addiction MD
Certified Alcohol and Drug Counselor
Social Worker
Biostatistician
CEHR Data Analyst
Trainers from Vermont
Personnel Total
Program Supplies
Monthly meeting food
Incentives
Care Notebooks
Program Total
Travel
APHA Annual Meeting registration
Flight
Lodging
Local travel
Travel Total

ANNUAL TOTAL
GRAND TOTAL (Year 1 + 2 + 3)

Salary

20.00% $130,000
70.00% $80,000
30.00% $52,000
20.00% $50,000
20.00% $225,000
10.00% $35,000
20.00% $45,000
0.00%
0.00%

$26,000
$56,000
$15,600
$10,000
$45,000
$3,500
$9,000

$165,100

Year 2
Fringe

Total

$7,611
$19,202
$6,445
$4,211
$11,649
$1,787
$3,999

$33,611
$75,202
$22,045
$14,211
$56,649
$5,287
$12,999

Effort

Salary

10.00% $133,900
80.00% $82,400
30.00% $53,560
20.00% $51,500
20.00% $231,750
20.00% $36,050
30.00% $46,350
5.00%
$85,000
20.00% $45,000

$5,000
$54,904 $225,004

Year 3
Fringe

$13,390
$65,920
$16,068
$10,300
$46,350
$7,210
$13,905
$4,250
$9,000

$3,889
$22,354
$2,922
$1,912
$5,102
$1,638
$2,731
$626
$1,797

$173,143

$40,546

Total
$17,279
$88,274
$18,990
$12,212
$51,452
$8,848
$16,636
$4,876
$10,797
$0
$229,362

Effort
10.00%
80.00%
40.00%
30.00%
20.00%
10.00%
30.00%
10.00%
40.00%

Salary
$137,917
$84,872
$55,166
$53,045
$238,702
$37,131
$47,740
$87,000
$47,000

Fringe
$13,792
$67,898
$22,066
$15,914
$47,740
$3,713
$14,322
$8,700
$18,800
$185,445

Total

$3,974
$22,774
$3,953
$2,908
$5,225
$829
$2,767
$1,270
$3,664

$17,766
$90,671
$26,019
$18,822
$52,965
$4,542
$17,089
$9,970
$22,464
$0
$42,430 $260,308

15 participants
$1,750
$4,600
$900
$7,250

2 staff members
2 staff members
2 staff members

30 participants

$1,750
$4,725
$900
$7,375

40 participants

$1,750
$3,825
$750
$6,325

$1,000
$1,000
$1,000
$2,000
$5,000

$1,000
$1,000
$1,000
$1,000
$4,000

$1,030
$1,000
$1,000
$1,000
$4,030

$237,254
$748,655

$240,737

$270,663

Year 1
Task
Planning phase
Conduct focus groups
Connect with community partners
Staff training
Meet with CAG
Submit abstract to APHA
Participant surveys
Process evaluation
Process evaluation dissimination
Develop CARE Notebook
Program enrollment open
Present at APHA meeting
Outcome evaluation
Prepare manuscripts

Q1

Q2

Year 2
Q3

Q4

Q1

Q2

Year 3
Q3

Q4

Q1

Q2

Q3

Q4

